[
  {
    "date": "2023-12-30",
    "symbol": "PTIXW",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-12555",
    "entityregistrantname": "Protagenic Therapeutics, Inc.\\new",
    "entitycentralindexkey": 1022899,
    "entitytaxidentificationnumber": "06-1390025",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "149     Fifth Avenue",
    "entityaddresscityortown": "New     York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10010,
    "cityareacode": "(212)",
    "localphonenumber": "994-8200",
    "security12btitle": "Common     Stock, par value $0.0001",
    "tradingsymbol": "PTIX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "true",
    "documentfinstmtrestatementrecoveryanalysisflag": "true",
    "auditorfirmid": 206,
    "auditorname": "MaloneBailey, LLP",
    "auditorlocation": "Houston, Texas",
    "cash": 1287893,
    "marketablesecuritiescurrent": 2768119,
    "prepaidexpensecurrent": 144025,
    "assetscurrent": 4200037,
    "propertyplantandequipmentnet": 123332,
    "assets": 4323369,
    "accountspayableandaccruedliabilitiescurrent": 439757,
    "liabilitiescurrent": 655252,
    "liabilities": 655252,
    "commonstockvalue": 444,
    "additionalpaidincapital": 34559091,
    "retainedearningsaccumulateddeficit": -30777872,
    "accumulatedothercomprehensiveincomelossnetoftax": -113546,
    "stockholdersequity": 3668117,
    "liabilitiesandstockholdersequity": 4323369,
    "preferredstockparorstatedvaluepershare": 0.000001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 4435132,
    "commonstocksharesoutstanding": 4435132,
    "researchanddevelopmentexpense": 3319867,
    "generalandadministrativeexpense": 1207107,
    "operatingexpenses": 4526974,
    "operatingincomeloss": -4526974,
    "investmentincomeinterest": 264476,
    "interestexpense": 107682,
    "realizedlossonmarketablesecurities": 630317,
    "nonoperatingincomeexpense": -473523,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -5000497,
    "netincomeloss": -5000497,
    "othercomprehensiveincomelossnetunrealizedlossonmarketablesecurities": 16848,
    "othercomprehensiveincomelossreclassicationofrealizedlossesondebtsecurities": 489120,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 57393,
    "comprehensiveincomenetoftax": -4437136,
    "earningspersharebasic": -1.15,
    "earningspersharediluted": -1.15,
    "weightedaveragenumberofsharesoutstandingbasic": 4344580,
    "weightedaveragenumberofdilutedsharesoutstanding": 4344580,
    "sharesoutstanding": 4435132,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossbeforereclassificationandtax": 57393,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": 16848,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 666828,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 10,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 104173,
    "othercomprehensiveincomereclassificationofrealizedlossesondebtsecurities": 489120,
    "stockissuedduringperiodsharesreversestocksplits": 9644,
    "depreciation": 28218,
    "sharebasedcompensation": 666828,
    "amortizationofdebtdiscountpremium": 85770,
    "increasedecreaseinprepaidexpense": 87086,
    "increasedecreaseinaccountspayableandaccruedliabilities": -27326,
    "netcashprovidedbyusedinoperatingactivities": -3703776,
    "proceedsfromsaleandmaturityofmarketablesecurities": 7689507,
    "paymentstoacquiremarketablesecurities": 2764250,
    "paymentstoacquireproductiveassets": 149775,
    "netcashprovidedbyusedininvestingactivities": 4775482,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 998,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 1072704,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 1287893,
    "stockissued1": 520867,
    "unrealizedgainorlossonmarketablesecurities": 16848,
    "investmentsfairvaluedisclosure": 2768119,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1357466,
    "realizedlossonmarketablesecuritiesincludesreclassificationofrealizedlosses": 489120,
    "marketablesecuritiesunrealizedgainloss": 16848,
    "marketablesecurities": 2768119,
    "propertyplantandequipmentusefullife": "P3Y",
    "accruedaccountingfees": 36750,
    "accruedresearchanddevelopment": 498366,
    "accruedprofessionalfeescurrent": 6334,
    "otheraccruedliabilitiescurrent": 113802,
    "accountspayableandotheraccruedliabilities": 655252,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1357466,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P4Y5M26D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 49832,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 14.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 68355,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 11.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 942566,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 19.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualterm": "P2Y3M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 594592,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirationsinperiodweightedaverageexerciseprice": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 186594,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1279181,
    "allocatedsharebasedcompensationexpense": 666828,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 676415,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsequityoutstandingweightedaverageexerciseprice": 19.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 138325,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsexpirationnumberofshares": 31250,
    "optionsexpirationdatedescription": "These have an exercise price of $4.00, $5.00 or $7.00 and areexercisable over a period ranging from 10 to 13 years.",
    "royaltypaymentpercentage": 0.025,
    "upfrontsublicensefeespercentage": 0.1,
    "royaltypaymentonbehalfofsublicenseepercentage": 0.025,
    "interestonamountsowedunderlicenseagreementrate": 0.03,
    "operatingcostsandexpenses": 149509,
    "otherliabilities": 150296,
    "othercommitment": 1300000,
    "otherliabilitiescurrent": 65199,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -4998066,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -2431,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.089,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.3,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 4940000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcostnet": 2131000,
    "deferredtaxassetsgross": 7071000,
    "deferredtaxassetsvaluationallowance": 7071000,
    "operatinglosscarryforwards": 15200000,
    "percentageofcorporationstaxableincome": 0.8,
    "operatinglosscarryforwardsexpirationdescription": "The federal net operating losses generated prior to 2018 of $0.1 million will expire at various dates through 2037.",
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1513000
  },
  {
    "date": "2022-12-30",
    "symbol": "PTIXW",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "000-51353",
    "entityregistrantname": "Protagenic Therapeutics, Inc.\\new",
    "entitycentralindexkey": 1022899,
    "entitytaxidentificationnumber": "06-1390025",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "149     Fifth Avenue",
    "entityaddresscityortown": "New     York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10010,
    "cityareacode": "(212)",
    "localphonenumber": "994-8200",
    "security12btitle": "Common     Stock, par value $0.0001",
    "tradingsymbol": "PTIX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 206,
    "auditorname": "MaloneBailey, LLP",
    "auditorlocation": "Houston, Texas",
    "cash": 215189,
    "marketablesecuritiescurrent": 7763517,
    "prepaidexpenseandotherassetscurrent": 56939,
    "assetscurrent": 8035645,
    "propertyplantandequipmentnet": 1775,
    "assets": 8037420,
    "accountspayableandaccruedliabilitiescurrent": 669704,
    "accountspayableandaccruedliabilitiesrelatedpartycurrent": 105928,
    "notespayablecurrent": 150591,
    "notespayablerelatedpartiesclassifiedcurrent": 193639,
    "liabilitiescurrent": 1119862,
    "liabilities": 1119862,
    "commonstockvalue": 434,
    "additionalpaidincapital": 33371406,
    "retainedearningsaccumulateddeficit": -25777375,
    "accumulatedothercomprehensiveincomelossnetoftax": -676907,
    "stockholdersequity": 6917558,
    "liabilitiesandstockholdersequity": 8037420,
    "preferredstockparorstatedvaluepershare": 0.000001,
    "preferredstocksharesauthorized": 20000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 4321315,
    "commonstocksharesoutstanding": 4321315,
    "researchanddevelopmentexpense": 1589239,
    "generalandadministrativeexpense": 1968549,
    "operatingexpenses": 3557788,
    "operatingincomeloss": -3557788,
    "investmentincomeinterest": 185790,
    "interestexpense": 137456,
    "debtsecuritiesavailableforsalerealizedloss": 46051,
    "nonoperatingincomeexpense": 2283,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3555505,
    "netincomeloss": -3555505,
    "othercomprehensiveincomelossnetunrealizedlossonmarketablesecurities": -421738,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -6820,
    "comprehensiveincomenetoftax": -3984063,
    "earningspersharebasic": -0.82,
    "weightedaveragenumberofsharesoutstandingbasic": 4317875,
    "sharesoutstanding": 4321315,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossbeforereclassificationandtax": -6820,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -421738,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 844248,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 2,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 18912,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 20433,
    "depreciation": 30,
    "sharebasedcompensation": 864681,
    "amortizationofdebtdiscountpremium": 110797,
    "increasedecreaseinprepaidexpense": -631728,
    "increasedecreaseinaccountspayableandaccruedliabilities": -91596,
    "netcashprovidedbyusedinoperatingactivities": -1993814,
    "saleofmarketablesecurities": 1632901,
    "paymentstoacquiremarketablesecurities": 34122,
    "paymentstoacquireproductiveassets": 1805,
    "netcashprovidedbyusedininvestingactivities": 1596974,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 70858,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -325982,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 215189,
    "stockissued1": 94985,
    "unrealizedlossonmarketablesecurities": 421738,
    "investmentsfairvaluedisclosure": 7763517,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1357466,
    "proceedsfromsaleandmaturityofmarketablesecurities": 1632901,
    "marketablesecuritiesrealizedgainloss": 46051,
    "marketablesecuritiesunrealizedgainloss": 421738,
    "marketablesecurities": 7763517,
    "accruedaccountingfeescurrentandnoncurrent": 36750,
    "accruedresearchanddevelopmentcurrentandnoncurrent": 557934,
    "accruedprofessionalfeescurrentandnoncurrent": 25462,
    "otheraccruedliabilitiescurrentandnoncurrent": 155486,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 775632,
    "debtinstrumentunamortizeddiscount": 79409,
    "debtconversionconvertedinstrumentsharesissued1": 18912,
    "debtinstrumentperiodicpaymentprincipal": 85000,
    "debtinstrumentperiodicpaymentinterest": 9985,
    "convertiblenotespayable": 230000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 4.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0173,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1357466,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y4M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 12500,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodweightedaverageremainingcontractualterm": "P9Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 35250,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 6.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 118187,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 13.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 96896,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 10.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 1537158,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 13.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualterm": "P2Y1M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 4000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantedweightedaverageremainingcontractualterm": "P4Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1543872,
    "allocatedsharebasedcompensationexpense": 844248,
    "unamortizedstockoptionexpense": 1342673,
    "unamortizedstockcompensationterm": "P3Y4M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsequityoutstandingweightedaverageexerciseprice": 13.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 138325,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsexpirationnumberofshares": 25000,
    "optionsexpirationdatedescription": "These have an exercise price of $4.00, $5.00 or $7.00 and areexercisable over a period ranging from 10 to 13 years.",
    "royaltypaymentpercentage": 0.025,
    "upfrontsublicensefeespercentage": 0.1,
    "royaltypaymentonbehalfofsublicenseepercentage": 0.025,
    "interestonamountsowedunderlicenseagreementrate": 0.03,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 105928,
    "duetorelatedpartiescurrentandnoncurrent": 105928,
    "othercommitment": 1300000,
    "agreementexpenses": 105801,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -3522834,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -32671,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.088,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.3,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 3620000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcostnet": 1931000,
    "deferredtaxassetsincometaxloss": 7000,
    "deferredtaxassetsgross": 5558000,
    "deferredtaxassetsvaluationallowance": 5558000,
    "operatinglosscarryforwards": 10800000,
    "percentageofcorporationstaxableincome": 0.8,
    "operatinglosscarryforwardsexpirationdescription": "Thefederal net operating losses generated prior to 2018 of $0.1 million will expire at various dates through 2037.",
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 137000
  },
  {
    "date": "2021-12-30",
    "symbol": "PTIXW",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "000-51353",
    "entityregistrantname": "Protagenic Therapeutics, Inc.\\new",
    "entitycentralindexkey": 1022899,
    "entitytaxidentificationnumber": "06-1390025",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "149     Fifth Avenue",
    "entityaddresscityortown": "New     York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10010,
    "cityareacode": "(212)",
    "localphonenumber": "994-8200",
    "security12btitle": "Common Stock, par value $0.0001",
    "tradingsymbol": "PTIX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 206,
    "auditorname": "MaloneBailey, LLP",
    "auditorlocation": "Houston, Texas",
    "cash": 541171,
    "marketablesecuritiescurrent": 9830085,
    "prepaidexpenseandotherassetscurrent": 688667,
    "assetscurrent": 11059923,
    "assets": 11059923,
    "accountspayableandaccruedliabilitiescurrent": 499535,
    "accountspayableandaccruedliabilitiesrelatedpartycurrent": 300000,
    "liabilitiescurrent": 799535,
    "convertiblelongtermnotespayable": 132284,
    "notespayablerelatedpartiesnoncurrent": 186149,
    "liabilities": 1117968,
    "commonstockvalue": 1722,
    "additionalpaidincapital": 32410452,
    "retainedearningsaccumulateddeficit": -22221870,
    "accumulatedothercomprehensiveincomelossnetoftax": -248349,
    "stockholdersequity": 9941955,
    "liabilitiesandstockholdersequity": 11059923,
    "preferredstockparorstatedvaluepershare": 0.000001,
    "preferredstocksharesauthorized": 20000000,
    "preferredstocksharesissued": 872766,
    "preferredstocksharesoutstanding": 872766,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 17209612,
    "commonstocksharesoutstanding": 17209612,
    "researchanddevelopmentexpense": 1136790,
    "generalandadministrativeexpense": 3003623,
    "operatingexpenses": 4140413,
    "operatingincomeloss": -4140413,
    "investmentincomeinterest": 33207,
    "interestexpense": 496912,
    "debtsecuritiesavailableforsalerealizedloss": 2486,
    "derivativegainlossonderivativenet": 83670,
    "nonoperatingincomeexpense": -382521,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -4522934,
    "netincomeloss": -4522934,
    "othercomprehensiveincomelossnetunrealizedlossonmarketablesecurities": -77029,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 266,
    "comprehensiveincomenetoftax": -4599697,
    "earningspersharebasicanddiluted": -0.31,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 14740825,
    "sharesoutstanding": 17209612,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossbeforereclassificationandtax": 266,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1518756,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -77029,
    "stockissuedduringperiodvaluestockoptionsexercised": 37,
    "stockissuedduringperiodsharesstockoptionsexercised": 370000,
    "stockissuedduringperiodvaluestockwarrantsexercised": 108,
    "stockissuedduringperiodsharesstockwarrantsexercised": 1076681,
    "issuanceofsharesandwarrantsfromofferingnetofofferingcosts": 318,
    "stockissuedduringperiodsharesissuanceofsharesandwarrantsfromoffering": 3180000,
    "stockissuedduringperiodvalueconversionofpreferredstock": -1,
    "stockissuedduringperiodshareconversionofpreferredstock": -872766,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 127,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 1270185,
    "stockissuedforunderwriter": 8,
    "stockissuedforunderwritershares": 79500,
    "sharebasedcompensation": 1518756,
    "amortizationofdebtdiscountpremium": 427137,
    "increasedecreaseinprepaidexpense": 480510,
    "increasedecreaseinaccountspayableandaccruedliabilities": 340121,
    "netcashprovidedbyusedinoperatingactivities": -2798614,
    "saleofmarketablesecurities": 485946,
    "paymentstoacquiremarketablesecurities": 10395547,
    "netcashprovidedbyusedininvestingactivities": -9909601,
    "proceedsfromdebtnetofissuancecosts": 327125,
    "proceedsfromconvertibledebt": 542500,
    "issuanceofsharesandwarrantsfromoffering": 11708039,
    "proceedsfromrelatedpartydebt": 100000,
    "repaymentsofnotespayable": 100000,
    "netcashprovidedbyusedinfinancingactivities": 12577664,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 631,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -129920,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 541171,
    "stockissued1": 1594968,
    "unrealizedlossonmarketablesecurities": 77029,
    "investmentsfairvaluedisclosure": 9830085,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -83670,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5520861,
    "proceedsfromsaleandmaturityofmarketablesecurities": 485946,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 77029,
    "marketablesecurities": 9830085,
    "derivativefairvalueofderivativenet": 127346,
    "classofwarrantorrightissued": 295945,
    "accruedaccountingfeescurrentandnoncurrent": 68151,
    "accruedresearchanddevelopmentcurrentandnoncurrent": 375427,
    "otheraccruedliabilitiescurrentandnoncurrent": 278947,
    "accountspayableandaccruedliabilitiescurrentandnoncurrent": 799535,
    "repaymentsofrelatedpartydebt": 7697,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 583000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.48,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 315000,
    "longtermdebt": 315000,
    "notespayable": 7500000,
    "debtinstrumentmaturitydate": "2026-02-28",
    "debtinstrumentinterestratestatedpercentage": 1.1,
    "debtinstrumentunamortizeddiscount": 182716,
    "debtconversionconvertedinstrumentsharesissued1": 1093519,
    "debtconversionconvertedinstrumentamount1": 1282500,
    "interestreceivable": 91593,
    "debtinstrumentunamortizedconverteddiscount": 186785,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5520861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y5M23D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodweightedaverageremainingcontractualterm": "P9Y1M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 290000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P6Y3M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 810333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 3.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 635500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 3.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 6132630,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 3.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualtermbeginning": "P1Y10M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 3657000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 4.98,
    "numberofwarrantsoutstandingweightedaverageremaininglifegranted": "P4Y9M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 150249,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirationsinperiodweightedaverageexerciseprice": 1.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 1381179,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisedinperiodweightedaverageexerciseprice": 1.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualtermending": "P3Y1M24D",
    "preferredstockconvertiblesharesissuable": 872766,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 5438449,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 430174,
    "allocatedsharebasedcompensationexpense": 1518756,
    "unamortizedstockoptionexpense": 2187130,
    "unamortizedstockcompensationterm": "P3Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsequityoutstandingweightedaverageexerciseprice": 3.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsaggregateintrinsicvalueoutstanding": 928802,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 553299,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsexpirationnumberofshares": 100000,
    "optionsexpirationdatedescription": "These have an exercise price of $1.00, $1.25 or 1.75 and areexercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October16, 2027 or on February 13, 2030",
    "royaltypaymentpercentage": 0.025,
    "upfrontsublicensefeespercentage": 0.1,
    "interestowedpercentage": 0.03,
    "proceedssettlementpercentage": 0.025,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 300000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -4522862,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -72,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.089,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.299,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 3779000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcostnet": 1672000,
    "deferredtaxassetsincometaxloss": -3000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 27000,
    "deferredtaxassetsgross": 5421000,
    "deferredtaxassetsvaluationallowance": 5421000,
    "operatinglosscarryforwards": 10935000,
    "percentageofcorporationstaxableincome": 0.8,
    "operatinglosscarryforwardsexpirationdescription": "The federal net operating losses generated prior to 2018 of $0.1 million will expire atvarious dates through 2037",
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1300000
  },
  {
    "date": "2020-12-30",
    "symbol": "PTIXW",
    "period": "FY",
    "entityregistrantname": "Protagenic Therapeutics, Inc.\\new",
    "entitycentralindexkey": 1022899,
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "cashandcashequivalentsatcarryingvalue": 671091,
    "prepaidexpensecurrent": 208156,
    "assetscurrent": 879247,
    "assets": 879247,
    "accountspayableandaccruedliabilitiescurrent": 571517,
    "derivativeliabilitiescurrent": 83670,
    "liabilitiescurrent": 655187,
    "convertiblelongtermnotespayable": 1081384,
    "convertiblelongtermnotespayablerelatedparty": 292412,
    "liabilities": 2028983,
    "preferredstockvalue": 1,
    "commonstockvalue": 1036,
    "additionalpaidincapital": 16719749,
    "retainedearningsaccumulateddeficit": -17698936,
    "accumulatedothercomprehensiveincomelossnetoftax": -171586,
    "stockholdersequity": -171586,
    "liabilitiesandstockholdersequity": 879247,
    "preferredstockparorstatedvaluepershare": 0.000001,
    "preferredstocksharesauthorized": 20000000,
    "preferredstocksharesissued": 872766,
    "preferredstocksharesoutstanding": 872766,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 10360480,
    "commonstocksharesoutstanding": 10360480,
    "researchanddevelopmentexpense": 699797,
    "generalandadministrativeexpense": 1851814,
    "operatingexpenses": 2551611,
    "operatingincomeloss": -2551611,
    "othernonoperatingincome": 502,
    "othernonoperatingexpense": 246178,
    "derivativegainlossonderivativenet": 248552,
    "nonoperatingincomeexpense": 2876,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -2548735,
    "netincomeloss": -2548735,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 778,
    "comprehensiveincomenetoftax": -2547957,
    "earningspersharebasicanddiluted": -0.25,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 10339071,
    "sharesoutstanding": 10360480,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossbeforereclassificationandtax": 778,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1427084,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 107670,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 104204,
    "issuanceofoptionsforsettlementofaccruedpayroll": 93950,
    "stockissuedduringperiodvalueissuedforservices": 119990,
    "stockissuedduringperiodsharesissuedforservices": 99061,
    "debtdiscountfromwarrantsissuedtoplacementagents": 179679,
    "depreciation": 286,
    "sharebasedcompensation": 1654754,
    "amortizationofdebtdiscountpremium": 37863,
    "increasedecreaseinprepaidexpense": 164802,
    "increasedecreaseinaccountspayableandaccruedliabilities": -196629,
    "netcashprovidedbyusedinoperatingactivities": -1348779,
    "paymentsofdebtissuancecosts": 104090,
    "proceedsfromconvertibledebt": 1177500,
    "proceedsfromrelatedpartydebt": 150000,
    "netcashprovidedbyusedinfinancingactivities": 1223410,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -2163,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -127532,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 671091,
    "debtinstrumentconvertiblebeneficialconversionfeature": 104204,
    "issuanceofoptionsforsettlementofaccountspayable": 93950,
    "propertyplantandequipmentusefullife": "P3Y",
    "derivativefairvalueofderivativenet": 127346,
    "classofwarrantorrightissued": 295945,
    "derivativeliabilitymeasurementinput": 169,
    "derivativeliabilities": -83670,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 83670,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 248552,
    "shareprice": 1.25,
    "derivativeliabilitymeasurementinputcontractualterm": "P0Y1M20D",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1598000,
    "registrationpaymentarrangementgainsandlosses": 174106,
    "registrationpaymentarrangementaccrualcarryingvalue": 319799,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y7D",
    "accruedaccountingfeescurrent": 36161,
    "accruedresearchanddevelopmentcurrent": 393496,
    "otheraccruedliabilitiescurrent": 141860,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1.25,
    "warrantsandrightsoutstandingterm": "P5Y",
    "debtinstrumentfaceamount": 665000,
    "debtinstrumentinterestratestatedpercentage": 0.06,
    "debtinstrumentconvertibleconversionprice1": 1.25,
    "paymentsforcommissions": 104090,
    "debtinstrumentunamortizeddiscount": 107588,
    "convertiblenotespayable": 400000,
    "additionalnotesrelatedfee": 9000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 400000,
    "longtermdebt": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4868623,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5597861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 38328,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1762495,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1,
    "allocatedsharebasedcompensationexpense": 72334,
    "unamortizedstockoptionexpense": 593138,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y11M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 527570,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 1.75,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 127346,
    "interestpayablecurrentandnoncurrent": 35000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 4007058,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsoutstandingweightedaverageexerciseprice": 1.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsnonoptionsaggregateintrinsicvalueoutstanding": 782668,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0161,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodweightedaverageremainingcontractualterm": "P9Y2M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P6Y5M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 862833,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 180400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 1.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 1.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualtermbeginning": "P2Y8M9D",
    "numberofwarrantsoutstandingweightedaverageremaininglifegranted": "P4Y6M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualtermending": "P1Y10M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 553299,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.75,
    "optionsexpirationdatedescription": "These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October 16, 2027 or on February 13, 2030.",
    "royaltypaymentpercentage": 0.025,
    "upfrontsublicensefeespercentage": 0.1,
    "royaltypaymentonbehalfofsublicenseepercentage": 0.025,
    "interestonamountsowedunderlicenseagreementrate": 0.03,
    "operatinglosscarryforwards": 100000,
    "percentageofcorporationstaxableincome": 1,
    "operatinglosscarryforwardsexpirationdescription": "The Canadian losses expire in stages beginning in 2026.",
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 418000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -2542428,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -6307,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.086,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.3,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 2907000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcostnet": 1217000,
    "deferredtaxassetsincometaxloss": 7000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10000,
    "deferredtaxassetsgross": 4121000,
    "deferredtaxassetsvaluationallowance": 4121000
  },
  {
    "date": "2019-12-30",
    "symbol": "PTIXW",
    "period": "FY",
    "entityregistrantname": "Protagenic Therapeutics, Inc.\\new",
    "entitycentralindexkey": 1022899,
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "cashandcashequivalentsatcarryingvalue": 798623,
    "prepaidexpensecurrent": 43354,
    "assetscurrent": 841977,
    "propertyplantandequipmentnet": 296,
    "assets": 842273,
    "accountspayableandaccruedliabilitiescurrent": 865047,
    "derivativeliabilitiescurrent": 332222,
    "liabilitiescurrent": 1197269,
    "convertiblelongtermnotespayable": 174821,
    "convertiblelongtermnotespayablerelatedparty": 104549,
    "liabilities": 1476639,
    "preferredstockvalue": 1,
    "commonstockvalue": 1026,
    "additionalpaidincapital": 14687172,
    "retainedearningsaccumulateddeficit": -15150201,
    "accumulatedothercomprehensiveincomelossnetoftax": -172364,
    "stockholdersequity": -172364,
    "liabilitiesandstockholdersequity": 842273,
    "preferredstockparorstatedvaluepershare": 0.000001,
    "preferredstocksharesauthorized": 18000000,
    "preferredstocksharesissued": 872766,
    "preferredstocksharesoutstanding": 872766,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 10261419,
    "commonstocksharesoutstanding": 10261419,
    "researchanddevelopmentexpense": 63905,
    "generalandadministrativeexpense": 1278183,
    "operatingexpenses": 2086130,
    "operatingincomeloss": -2086130,
    "othernonoperatingincome": 2813,
    "othernonoperatingexpense": 15886,
    "availableforsalesecuritiesgrossrealizedgainlossnet": 4435,
    "derivativegainlossonderivativenet": 343857,
    "nonoperatingincomeexpense": 335219,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -1750911,
    "netincomeloss": -1750911,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -6647,
    "comprehensiveincomenetoftax": -1757558,
    "earningspersharebasicanddiluted": -0.17,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 10261419,
    "sharesoutstanding": 10261419,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": 4823,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationgainlossbeforereclassificationandtax": -6647,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 797761,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 402000,
    "adjustmentstoadditionalpaidincapitalissuanceofoptions": 129491,
    "depreciation": 339,
    "sharebasedcompensation": 797761,
    "amortizationofdebtdiscountpremium": 4549,
    "gainslossesonextinguishmentofdebt": -99541,
    "increasedecreaseinprepaidexpense": -40044,
    "increasedecreaseinaccountspayableandaccruedliabilities": 662158,
    "netcashprovidedbyusedinoperatingactivities": -487990,
    "proceedsfromsaleofavailableforsalesecurities": 250000,
    "netcashprovidedbyusedininvestingactivities": 250000,
    "proceedsfromconvertibledebt": 420000,
    "proceedsfromrelatedpartydebt": 250000,
    "netcashprovidedbyusedinfinancingactivities": 670000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 4127,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 436137,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 798623,
    "unrealizedgainlossonmarketablesecurities": 4823,
    "debtinstrumentconvertiblebeneficialconversionfeature": 252000,
    "debtdiscountfromconversionfeaturerelatedparty": 150000,
    "issuanceofoptionsforsettlementofaccountspayable": 29950,
    "propertyplantandequipmentusefullife": "P3Y",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": 4823,
    "fairvalueofderivativefeature": 127346,
    "classofwarrantorrightissued": 295945,
    "derivativeliabilities": 332222,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 332222,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 343857,
    "fairvalueassumptionsexrciseprice": 1.25,
    "fairvalueassumptionspercentage": 1.33,
    "fairvalueassumptionscontractualterm": "P1Y1M24D",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 536000,
    "registrationpaymentarrangementaccrualcarryingvalue": 493905,
    "accruedaccountingfeescurrent": 36161,
    "accruedresearchanddevelopmentcurrent": 650584,
    "accruedlegalfeescurrent": 15273,
    "otheraccruedliabilitiescurrent": 163029,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1.05,
    "debtinstrumentfaceamount": 250000,
    "debtinstrumentinterestratestatedpercentage": 0.06,
    "debtinstrumentconvertibleconversionprice1": 1.25,
    "beneficialconversionfeatureanddebtdiscount": 150000,
    "debtinstrumentunamortizeddiscount": 154451,
    "convertiblenotespayable": 250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4304245,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3835366,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 635536,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 126567,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1,
    "allocatedsharebasedcompensationexpense": 562734,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 510903,
    "unamortizedstockoptionexpense": 287905,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 143482,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y11M23D",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 423291,
    "interestpayablecurrentandnoncurrent": 35000,
    "classofwarrantorrightexpirationperiod": "P5Y",
    "classofwarrantorrightoutstanding": 3826658,
    "classofwarrantorrightoutstandingweightedaverageexerciseprice": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 1375990,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.027,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 137500,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodweightedaverageremainingcontractualterm": "P9Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P6Y0M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 204382,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 137500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 1.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 3826658,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualtermbeginning": "P3Y8M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageremainingcontractualtermending": "P2Y8M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 533299,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.75,
    "optionsexpirationdatedescription": "These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027 or on October 16, 2027.",
    "royaltypaymentpercentage": 0.025,
    "upfrontsublicensefeespercentage": 0.1,
    "royaltypaymentonbehalfofsublicenseepercentage": 0.025,
    "interestonamountsowedunderlicenseagreementrate": 0.03,
    "operatinglosscarryforwards": 1111000,
    "operatinglosscarryforwardsexpirationdescription": "The Canadian losses expire in stages beginning in 2026.",
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 661000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -1698689,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -52222,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -1750911,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.086,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.302,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 2894000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcostnet": 784000,
    "deferredtaxassetsincometaxloss": 29000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4000,
    "deferredtaxassetsgross": 3703000,
    "deferredtaxassetsvaluationallowance": 3703000
  }
]